CAS: 1628614-50-5
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
5,11-Dihydro-5,11-dimethyl-2-[[1-(4-piperidinyl)-1H-pyrazol-4-yl]amino]-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one REF: 3D-DQC61450CAS: 1628614-50-5 | Min. 95% | A consultar | Vie 28 Jun 24 | |
XMD-17-51 REF: TM-T22460CAS: 1628614-50-5 | 98% | 907,00 €~2.337,00 € | Vie 05 Jul 24 |
5,11-Dihydro-5,11-dimethyl-2-[[1-(4-piperidinyl)-1H-pyrazol-4-yl]amino]-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one
CAS:1628614-50-5
5,11-Dihydro-5,11-dimethyl-2-[[1-(4-piperidinyl)-1H-pyrazol-4-yl]amino]-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one is a small molecule that binds to the Nmethyl D aspartate receptor (NMDAR). It …
Fórmula:
C21H24N8O
Pureza:
Min. 95%
Peso molecular:
404.5 g/mol
Ref: 3D-DQC61450
5mg | A consultar | |
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 28 de Junio de 2024
XMD-17-51
CAS:1628614-50-5
XMD-17-51 is a potent and highly selective NUAK1 inhibitor.
Fórmula:
C21H24N8O
Pureza:
98%
Forma y color:
Solid
Peso molecular:
404.47
Ref: TM-T22460
25mg | 1.410,00 € | |
50mg | 1.851,00 € | |
100mg | 2.337,00 € |
Entrega estimada en Estados Unidos, el Viernes 5 de Julio de 2024